Skip to main content
. 2020 May 20;10(5):73. doi: 10.3390/life10050073

Figure 1.

Figure 1

Low density lipoprotein cholesterol (LDL-C) reduction (%) after rosuvastatin treatment in polygenic and monogenic subjects. The data are presented as mean and 95% CI (IPWRA model).